Related Experiment Video
Updated: May 26, 2026
09:02
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Immune reconstitution in chronic lymphocytic leukemia
John C Riches1, Alan G Ramsay, John G Gribben
1Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, UK. johnriches@doctors.org.uk
Current Hematologic Malignancy Reports
|January 11, 2012
Summary
Chronic lymphocytic leukemia (CLL) causes immune defects, increasing infection risk and hindering anti-tumor responses. New therapies like gene therapy and immunotherapy offer hope for improving immune function in CLL patients.
Area of Science:
- Immunology
- Oncology
- Hematology
Background:
- Chronic lymphocytic leukemia (CLL) is characterized by significant immune dysfunction.
- This immune defect leads to heightened susceptibility to infections and impaired anti-tumor immunity.
- Conventional chemotherapy can exacerbate immune suppression, limiting treatment options for vulnerable patients.
Purpose of the Study:
- To review the immune defect in Chronic lymphocytic leukemia (CLL).
- To discuss therapeutic strategies for restoring or bypassing immune deficiencies in CLL.
- To highlight recent advancements in novel immunotherapies for CLL.
Main Methods:
- Literature review of immune defects in CLL.
- Analysis of emerging therapeutic strategies.
- Focus on CD40 ligand gene therapy, immunomodulatory drugs, and CAR T-cell therapy.
Main Results:
- CLL patients exhibit profound immune suppression affecting both innate and adaptive immunity.
- Current treatments often fail to address the underlying immune defect and can worsen it.
- Novel approaches show promise in modulating the immune system to fight CLL.
Conclusions:
- Addressing the immune defect is critical for effective CLL management.
- Gene therapy, immunomodulatory agents, and adoptive T-cell transfer represent promising avenues.
- These strategies may offer improved outcomes, especially for elderly and frail patients.
